Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Sale |
2024-12-18 4:35 pm |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
6,300 | $2.34 | $14,742 | 14,653 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-22 4:15 pm |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
3,265 | $23.73 | $77,478 | 5,735 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-04-17 4:57 pm |
N/A N/A |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
13,350 | $0 | 57,003 (Direct) |
View |
| 2024-12-18 Option Award |
2024-12-20 8:45 pm |
N/A 2034-12-17 |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
68,000 | $0 | 82,653 (Direct) |
View |
| 2024-02-19 Option Award |
2024-07-08 4:30 pm |
N/A N/A |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
15,218 | $0 | 20,953 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-12 4:23 pm |
N/A 2033-09-10 |
GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-02-17 Option Award |
2023-05-02 4:21 pm |
N/A N/A |
GENELUX CORP | GNLX | Cappello Joseph VP, Pharmaceutical Development |
9,000 | $0 | 9,000 (Direct) |
View |
Ownership |
2023-01-25 7:24 pm |
N/A 2025-04-30 |
GENELUX CORP | GNLX | Cappello Joseph VP, Pharmaceutical Development |
0 | $0 | 159,999 (Direct) |
View |